News summary

Adipose Buffering Failure and Organ Reserve in Lean Cardiovascular–Kidney–Metabolic Vulnerability: A Testable Endocrine Hypothesis

Source: Frontiers - Health • Published: 09 Oct 2026, 00:00

Summarized by Masters of Longevity from Frontiers - Health.

Adipose buffering failure and organ reserve are presented as an explanatory hypothesis for lean cardiovascular–kidney–metabolic vulnerability; the article lays out how this theory could be tested and validated.

Adipose Buffering Failure and Organ Reserve in Lean Cardiovascular–Kidney–Metabolic Vulnerability: A Testable Endocrine Hypothesis
Key Takeaways
  • The paper hypothesizes that impaired dynamic adipose lipid handling increases CKM risk when organ-specific adaptive reserve is limited.
  • A core measurement set is proposed: dynamic NEFA suppression, DXA/MRI body composition, an oral disposition index, and kidney trajectory.
  • A staged proof ladder with prespecified falsification criteria and priority validation in South and Southeast Asian populations is outlined.
Read the full article at Frontiers - Health ↗

Continue exploring

Recommended MoL Picks

MoL PickApoB: The cholesterol signal LDL can missIn longevity medicine, the useful biomarkers are not always the exotic ones. ApoB is a relatively simple blood test that can sharpen cardiovascular prevention when LDL-C looks reassuring but particle burden remains high.MoL PickSemaglutide Extended Lifespan in Mice. What Would Make It a Human Longevity Drug?A new animal study sharpens an important question: when do benefits in a particular disease become evidence for a longer, healthier life?MoL PickThe Next Obesity-Drug Race Is About What Weight You LoseRegeneron’s myostatin and activin A antibodies point to a sharper question for the GLP-1 era: not whether people can lose more weight, but whether medicine can preserve the tissue that makes weight loss healthier.